$CYTK News

Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700

Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics (CYTK) Q2 2026 Earnings Call Transcript

Barclays Maintains Overweight on Cytokinetics, Raises Price Target to $110

JP Morgan Maintains Overweight on Cytokinetics, Raises Price Target to $103

Truist Securities Maintains Buy on Cytokinetics, Raises Price Target to $112

Cytokinetics (CYTK) Stock Looks Near Fair Value Despite UK MYQORZO Approval

RBC Capital Maintains Outperform on Cytokinetics, Lowers Price Target to $112

Cytokinetics, Incorporated Q2 2026 Earnings Call Summary

Citizens Maintains Market Outperform on Cytokinetics, Raises Price Target to $110

Needham Maintains Buy on Cytokinetics, Raises Price Target to $112

Cytokinetics Inc (CYTK) (Q2 2026) Earnings Call Highlights: Mycorzo Launch Momentum and ...

Cytokinetics Q2 Earnings Call Highlights

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Cytokinetics (NASDAQ:CYTK) Beats Q2 Estimates on Strong MYQORZO Launch

Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update

Cytokinetics Q2 EPS $(1.50) Beats $(1.63) Estimate, Sales $28.624M Beat $17.382M Estimate

Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today